Emergency Use Authorizations issued by the US Food and Drug Administration during the COVID-19 pandemic will remain in effect even after the public health emergency comes to an end on 11 May, US Secretary of Health and Human Services Xavier Becerra clarified in a 20 March Federal Register notice.
President Joe Biden announced last month that his administration will not reauthorize the PHE, which had been renewed every 90 days since February 2020, after it expires in May. While...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?